Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy

European Urology

Volumn 41, Issue 4, 2002, Pages 440-448

  Gschwend, Jürgen E ^a,b   Dahm, Philipp ^c   Fair, William R ^b  

^a UNIVERSITY OF ULM   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Disease specific survival; Prognostic factors; Radical cystectomy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 0036555446     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00060-X     Document Type: Article

References (19)

1. Montie JE. Against bladder sparing surgery. J Urol 1999;162:452-7.
2. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W. et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
3. Lerner SP, Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: Long term results. J Urol 1993;149:758-65.
4. Soloway MS, Lopez AE, Patel J, Ying L. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1993;73(7):1926-31.
5. Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, et al. Skinner DG. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995;76(5):833-9.
6. Bassi P, Ferrante GD, Piazza N, Spinadin R, Carando R, Pappagallo G, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort. J Urol 1999;161:1494-7.
7. Frazier HA, Robertson JE, Dodge RK, Paulson DF, et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993;71:3993-4001.
8. Vieweg J, Gschwend JE, Herr HW, Fair WR. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999;161:72-6.
9. Vieweg J, Gschwend JE, Herr HW, Fair WR. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999;161:449-54.
10. American joint committee on cancer. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for Staging of Cancer. 4th Ed. Philadelphia (PA): JB Lippincott, 1992. pp. 199-200.
11. TNM classification of malignant tumors. In: Hermanek P, Sobin LH, editors. International Union Against Cancer, 4th Ed. New York: Springer, 1987. p. 143.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen S, Groshen S, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996;156:1071-6.
14. Vieweg J, Whitmore Jr WF, Herr HW, Sogani PC, Russo P, Sheinfeld J, et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. Cancer 1994;73(12):3020-8.
15. BA06/30894 trial. Neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomized controlled trial. Lancet 1999;354:533-40.
16. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 1991;145:459-64.
17. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, et al. Adjuvant polychemotherapy of non-organ-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience. J Urol 1995;153:47-52.
18. Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle-invasive bladder cancer. J Urol 1996;155:495-500.
19. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why. Ann Oncol 2000;11(7):851-6.